Department of Radiation Oncology, Beth Israel Medical Center, New York, NY, USA.
Radiat Oncol. 2011 May 9;6:45. doi: 10.1186/1748-717X-6-45.
The goal of this study was to evaluate the use of 3D ultrasound (3DUS) breast IGRT for electron and photon lumpectomy site boost treatments.
20 patients with a prescribed photon or electron boost were enrolled in this study. 3DUS images were acquired both at time of simulation, to form a coregistered CT/3DUS dataset, and at the time of daily treatment delivery. Intrafractional motion between treatment and simulation 3DUS datasets were calculated to determine IGRT shifts. Photon shifts were evaluated isocentrically, while electron shifts were evaluated in the beam's-eye-view. Volume differences between simulation and first boost fraction were calculated. Further, to control for the effect of change in seroma/cavity volume due to time lapse between the 2 sets of images, interfraction IGRT shifts using the first boost fraction as reference for all subsequent treatment fractions were also calculated.
For photon boosts, IGRT shifts were 1.1 ± 0.5 cm and 50% of fractions required a shift >1.0 cm. Volume change between simulation and boost was 49 ± 31%. Shifts when using the first boost fraction as reference were 0.8 ± 0.4 cm and 24% required a shift >1.0 cm. For electron boosts, shifts were 1.0 ± 0.5 cm and 52% fell outside the dosimetric penumbra. Interfraction analysis relative to the first fraction noted the shifts to be 0.8 ± 0.4 cm and 36% fell outside the penumbra.
The lumpectomy cavity can shift significantly during fractionated radiation therapy. 3DUS can be used to image the cavity and correct for interfractional motion. Further studies to better define the protocol for clinical application of IGRT in breast cancer is needed.
本研究旨在评估三维超声(3DUS)在电子和光子保乳术后瘤床加量治疗中的应用。
本研究纳入了 20 例接受光子或电子瘤床加量治疗的患者。在模拟定位时和每日治疗时采集 3DUS 图像,以形成配准的 CT/3DUS 数据集。计算治疗和模拟 3DUS 数据集之间的分次内运动,以确定图像引导放疗(IGRT)的移位。对光子移位进行等中心评估,而对电子移位进行视线评估。计算模拟和首次加量分次之间的体积差异。此外,为了控制由于 2 组图像之间的时间间隔导致的囊腔/间隙体积变化的影响,还使用首次加量分次作为所有后续治疗分次的参考,计算分次间 IGRT 移位。
对于光子瘤床加量,IGRT 移位为 1.1±0.5cm,50%的分次需要移位>1.0cm。模拟和加量之间的体积变化为 49±31%。使用首次加量分次作为参考时,移位为 0.8±0.4cm,24%的分次需要移位>1.0cm。对于电子瘤床加量,移位为 1.0±0.5cm,52%的移位超出了剂量学半影区。相对于首次分次的分次间分析表明,移位为 0.8±0.4cm,36%的移位超出了半影区。
在分次放射治疗过程中,保乳术后瘤腔可能会发生显著移位。3DUS 可用于成像瘤腔并校正分次间运动。需要进一步的研究来更好地定义在乳腺癌中应用 IGRT 的临床应用方案。